GLP-1 and GIP target areas in your brain to help decrease appetite and slow down digestion to help you feel full faster and longer
GLP-1R is expressed in several brain regions, including the hippocampus and cortex, where it may influence synaptic plasticity, neuroinflammation, and cellular energy metabolism [88,89]
Si des antcdents sont connus chez le patient, un traitement pour limiter les risques pourra tre mis en place
Mitochondrial dysfunction: pathophysiology and mitochondria-targeted drug delivery approaches
Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer
The Ministry of Health (MOH) told CNA TODAY that the number of patients using semaglutide injections such as Ozempic and Wegovy rose from about 1,500 in 2023 to about 6,400 in 2025